Glycated haemoglobin A1c for diagnosing diabetes in Chinese population: Cross sectional epidemiological survey

BMJ (Online)

Volumn 340, Issue 7757, 2010, Pages 1178-

  Bao, Yuqian ^a   Ma, Xiaojing ^a   Li, Huating ^a   Zhou, Mi ^a   Hu, Cheng ^a   Wu, Haiya ^a   Tang, Junling ^a   Hou, Xuhong ^a   Xiang, Kunsan ^a   Jia, Weiping ^a  

^a Shanghai Clinical Center of Diabetes   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ADULT; AGED; ARTICLE; CHINESE; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; MAJOR CLINICAL STUDY; MALE; PERFORMANCE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADULT; AGED; AREA UNDER CURVE; BLOOD GLUCOSE; CHINA; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS; FEMALE; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; MALE; MIDDLE AGED; REFERENCE STANDARDS; SENSITIVITY AND SPECIFICITY; YOUNG ADULT;

EID: 77953936972     PISSN: None     EISSN: 17561833     Source Type: Journal    
DOI: 10.1136/bmj.c2249     Document Type: Article

References (35)

1. Saudek CD, Herman WH, Sacks DB, Bergenstal RM, Edelman D, Davidson MB. A new look at screening and diagnosing diabetes mellitus. J Clin Endocrinol Metab 2008;93:2447-53.
2. Jia WP, Pang C, Chen L, Bao YQ, Lu JX, Lu HJ, et al. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 2007;50:286-92.
3. World Health Organization. The world health report: primary health care - now more than ever. WHO, 2008.
4. World Health Organization. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. WHO, 1999.
5. Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Report of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(suppl 1):S5-20.
6. Little RR, Rohlfing CL, Wiedmeyer HM, Myers GL, Sacks DB, Goldstein DE, et al. The national glycohemoglobin standardization program: a five-year progress report. Clin Chem 2001;47:1985-92.
7. Little RR. Glycated hemoglobin standardization - national glycohemoglobin standardization program (NGSP) perspective. Clin Chem Lab Med 2003;41:1191-8.
8. Goldstein DE, Little RR, Lorenz RA,Malone JI, Nathan D, Peterson CM, et al. Tests of glycemia in diabetes. Diabetes Care 2004;27:1761-73.
9. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 2000;321:405-12.
10. Buell C, Kermah D, Davidson MB. Utility of A1C for diabetes screening in the 1999-2004 NHANES population. Diabetes Care 2007;30:2233-5.
11. 1c) in screening for undiagnosed diabetes in the US population. Diabetes Care 2000;23:187-91.
12. Nakagami T, Tominaga M, Nishimura R, Yoshiike N, Daimon M, Oizumi T, et al. Is the measurement of glycated hemoglobin A1c alone an efficient screening test for undiagnosed diabetes? Japan National Diabetes Survey. Diabetes Res Clin Pract 2007;76:251-6.
13. Wiener K, Roberts NB. The relative merits of haemoglobin A1c and fasting plasma glucose as first-line diagnostic tests for diabetes mellitus in non-pregnant subjects. Diabet Med 1998;15:558-63.
14. Barr RG, Nathan DM, Meigs JB, Singer DE. Tests of glycemia for the diagnosis of type 2 diabetes mellitus. Ann Intern Med 2002;137:263-72.
15. Bennett CM, Guo M, Dharmage SC. HbA(1c) as a screening tool for detection of type 2 diabetes: a systematic review. Diabet Med 2007;24:333-43.
16. International Expert Committee. International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes. Diabetes Care 2009;32:1327-34.
17. Olabi B, Bhopal R. Diagnosis of diabetes using the oral glucose tolerance test. BMJ 2009;339:b4354.
18. WHO Expert Committee on Diabetes Mellitus. Second report. Technical report series no 646. WHO, 1980.
19. Hanley JA, McNeil BJ. Amethod of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983;148:839-43.
20. Zhou B, Wu Y, Yang J, Li Y, Zhang H, Zhao L. Overweight is an independent risk factor for cardiovascular disease in Chinese populations. Obes Rev 2002;3:147-56.
21. ACE/ADA Task Force on Inpatient Diabetes. American College of Endocrinology and American Diabetes Association consensus statement on inpatient diabetes and glycaemic control. Diabetes Care 2006;29:1955-62.
22. 1c determination. Diabetologia 2004;47:1143-8.
23. Selvin E, Crainiceanu CM, Brancati FL, Coresh J. Short-term variability in measures of glycemia and implications for the classification of diabetes. Arch Intern Med 2007;167:1545-51.
24. Lacher DA, Hughes JP, Carroll MD. Estimate of biological variation of laboratory analytes based on the third national health and nutrition examination survey. Clin Chem 2005;51:450-2.
25. Perry RC, Shankar RR, Fineberg N, McGill J, Baron AD. HbA1c measurement improves the detection of type 2 diabetes in high-risk individuals with nondiagnostic levels of fasting plasma glucose: the Early Diabetes Intervention Program (EDIP). Diabetes Care 2001;24:465-71. (Pubitemid 32198414)
26. DECODE Study Group on behalf of the European Diabetes Epidemiology Study Group. Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data. BMJ 1998;317:371-5.
27. DECODE Study Group. Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria. Arch Intern Med 2001;161:397-405.
28. Qiao Q, Nakagami T, Tuomilehto J, Borch-Johnsen K, Balkau B, Iwamoto Y, et al. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia 2000;43:1470-5.
29. Yang ZJ, Yang WY, Li GW; National Diabetes Prevention and Control Cooperative Group. The distributive characteristics of impaired glucose metabolism subcategories in Chinese adult population. Zhonghua Yi Xue Za Zhi 2003;83:2128-31.
30. Herman WH, Ma Y, Uwaifo G, Haffner S, Kahn SE, Horton ES, et al. Differences in A1C by race and ethnicity among patients with impaired glucose tolerance in the Diabetes Prevention Program. Diabetes Care 2007;30:2753-7.
31. Viberti G, Lachin J, Holman R, Zinman B, Haffner S, Kravitz B, et al. A Diabetes Outcome Progression Trial (ADOPT): baseline characteristics of type 2 diabetic patients in North America and Europe. Diabet Med 2006;23:1289-94.
32. Anand SS, Razak F, Vuksan V, Gerstein HC, Malmberg K, Yi Q, et al. Diagnostic strategies to detect glucose intolerance in a multiethnic population. Diabetes Care 2003;26:290-6.
33. 1c or fructosamine predicts the likelihood of having diabetes in high-risk subjects. Diabetes Care 1998;21:1221-5.
34. Harris MI. Undiagnosed NIDDM: clinical and public health issues. Diabetes Care 1993;16:642-52.
35. Zhang Y, Dall TM,Mann SE, Chen Y, Martin J, Moore V, et al. The economic costs of undiagnosed diabetes. Popul Health Manag 2009;12:95-101.